← Eichor
Study identifier: NCT05164107 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation

Condition: Atrial Fibrillation  ·  Sponsor: Kardium Inc.

PhaseNA
Planned participants175
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The purpose of this study is to provide clinical data pertaining to the safety and performance of the Globe Mapping and Pulsed Field Ablation System for treating subjects with atrial fibrillation (AF).

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Affairs  ·  +1 (604) 248 8891  ·  Clinical.Affairs@kardium.com

Always discuss trial participation with your own doctor first.

Locations (1)

Motol and Homolka University HospitalPrague, CzechiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05164107